Ignite Creation Date:
2025-12-24 @ 6:38 PM
Ignite Modification Date:
2026-01-16 @ 11:11 AM
Study NCT ID:
NCT00775957
Status:
TERMINATED
Last Update Posted:
2010-09-28
First Post:
2008-10-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgkin's Lymphoma
Sponsor:
University of Oklahoma
Organization:
Study Overview
Official Title:
Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgknin's Lymphoma
Status:
TERMINATED
Status Verified Date:
2010-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Terminated by institutional review board
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A study to determine the accuracy of FLT-PET in quantifying tumor cell proliferation at the initial staging of patients with Non-Hodgkin's Lymphoma in comparison wit the "gold standard" FDG-PET.
Detailed Description:
The first primary objective reflects a necessary and preliminary requirement: to reproduce published results and validate the use of FLT-PET. In this study, 35 patients will be selected to undergoing imaging with both FLT and FDG PET.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: